HomeCompareANAT vs PFE

ANAT vs PFE: Dividend Comparison 2026

ANAT yields 52.52% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ANAT wins by $437.5K in total portfolio value
10 years
ANAT
ANAT
● Live price
52.52%
Share price
$188.99
Annual div
$99.26
5Y div CAGR
0.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$487.1K
Annual income
$107,567.34
Full ANAT calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ANAT vs PFE

📍 ANAT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodANATPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ANAT + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ANAT pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANAT
Annual income on $10K today (after 15% tax)
$4,464.31/yr
After 10yr DRIP, annual income (after tax)
$91,432.24/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ANAT beats the other by $69,112.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANAT + PFE for your $10,000?

ANAT: 50%PFE: 50%
100% PFE50/50100% ANAT
Portfolio after 10yr
$268.3K
Annual income
$66,913.03/yr
Blended yield
24.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ANAT
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANAT buys
0
PFE buys
0
No recent congressional trades found for ANAT or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricANATPFE
Forward yield52.52%6.13%
Annual dividend / share$99.26$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.6%13.2%
Portfolio after 10y$487.1K$49.6K
Annual income after 10y$107,567.34$26,258.71
Total dividends collected$396.6K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ANAT vs PFE ($10,000, DRIP)

YearANAT PortfolioANAT Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$15,984$5,283.64$9,153$693.39+$6.8KANAT
2$25,043$7,940.05$8,593$849.25+$16.4KANAT
3$38,492$11,696.08$8,336$1,066.78+$30.2KANAT
4$58,088$16,902.16$8,437$1,384.80+$49.7KANAT
5$86,136$23,981.59$9,013$1,875.40+$77.1KANAT
6$125,599$33,434.04$10,306$2,680.72+$115.3KANAT
7$180,227$45,835.98$12,820$4,101.38+$167.4KANAT
8$254,681$61,837.76$17,673$6,826.70+$237.0KANAT
9$354,666$82,156.86$27,543$12,591.86+$327.1KANAT
10$487,060$107,567.34$49,560$26,258.71+$437.5KANAT

ANAT vs PFE: Complete Analysis 2026

ANATStock

American National Group, Inc., together with its subsidiaries, provides life insurance, annuities, property and casualty insurance, health insurance, credit insurance, and pension products in the United States, the District of Columbia, and Puerto Rico. It operates through five segments: Life, Annuity, Health, Property and Casualty, and Corporate and Other. The Life segment offers whole life, term life, universal life, variable universal life, and credit life insurance products. The Annuity segment provides deferred, single premium immediate, and variable annuity products. The Health segment offers medicare supplement, supplemental, stop-loss, credit disability, and medical expense insurance products. The Property and Casualty segment provides personal lines insurance, such as auto, homeowners, boats, motorcycles, recreational vehicles, and other exposures; commercial lines of insurance, including property and casualty coverage tailored for a farm, ranch, or other agricultural business, as well as business owners' property and liability, workers' compensation insurance, and other commercial insurance; and specialty markets products comprising collateral or creditor protection insurance, and guaranteed auto protection or guaranteed asset protection insurance. The Corporate and Other segment engages in the investment activities. The company distributes its products through career, multiple-line, and independent agents, as well as direct marketing channels; brokers and financial institutions; managing general underwriters; and multiple-line and managing general agents. American National Group, Inc. was incorporated in 1905 and is headquartered in Galveston, Texas.

Full ANAT Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ANAT vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANAT vs SCHDANAT vs JEPIANAT vs OANAT vs KOANAT vs MAINANAT vs JNJANAT vs MRKANAT vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.